Encore Medical L.P.: FDA filings under this applicant name
FDA lists 82 510(k) clearances under the applicant name “Encore Medical L.P.” (first 2002, latest 2026), across 17 product codes in 2 review panels. Median 510(k) review time under this name: 93 days. Since 2017 the median was 90 days, against 101 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Enovis (DJO), based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 6 | 64 |
| 2013 | 5 | 222 |
| 2014 | 5 | 108 |
| 2015 | 1 | 184 |
| 2016 | 4 | 112 |
| 2017 | 6 | 90 |
| 2018 | 2 | 90 |
| 2019 | 3 | 74 |
| 2020 | 2 | 138 |
| 2021 | 2 | 60 |
| 2022 | 2 | 191 |
| 2023 | 1 | 301 |
| 2024 | 1 | 216 |
| 2025 | 7 | 71 |
| 2026 | 2 | 92 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Encore Medical L.P. took a median 90 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 101 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| PHX | Shoulder Prosthesis, Reverse Configuration | 17 | 17 |
| JWH | Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer | 15 | 15 |
| LPH | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented | 12 | 12 |
| KWS | Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented | 9 | 9 |
| KWA | Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component) | 5 | 5 |
| OIY | Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer + Additive/Metal/Polymer + Additive | 4 | 4 |
| KWQ | Appliance, Fixation, Spinal Intervertebral Body | 3 | 3 |
| KWZ | Prosthesis, Hip, Constrained, Cemented Or Uncemented, Metal/Polymer | 3 | 3 |
| LZO | Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented | 3 | 3 |
| OQG | Hip Prosthesis, Semi-Constrained, Cemented, Metal/Polymer, + Additive, Porous, Uncemented | 3 | 3 |
Plus 7 more product codes.
Review panels
- Orthopedic (81)
- Physical Medicine (1)
Most recent Encore Medical L.P. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K263086 | AltiVate Reverse® Glenosphere with RAVN Technology | PHX | 2026-10-02 | 30 |
| K252567 | AltiVate Reverse® ADLC Glenosphere | PHX | 2026-01-15 | 154 |
| K252974 | EMPOWR Knee | JWH | 2025-12-19 | 93 |
| K251833 | EMPOWR Acetabular® Liner Extension | LPH | 2025-11-12 | 149 |
| K252141 | AltiVate Reverse® Glenoid | PHX | 2025-08-05 | 28 |
| K251776 | EMPOWR Revision Knee (EMPOWR Revision VVC+, e+ Tibial Insert) | JWH | 2025-07-08 | 28 |
| K251241 | EMPOWR Revision Knee (EMPOWR Revision Knee Symmetric TT Cones) | JWH | 2025-07-02 | 71 |
| K251184 | AltiVate Reverse Shoulder System; RSP Shoulder System; SMR Shoulder System; PRIMA Humeral System; PRIMA Glenoid System | PHX | 2025-05-16 | 30 |
| K241483 | ceramys femoral head system | LZO | 2025-02-07 | 259 |
| K233481 | AltiVate Reverse® Glenoid | PHX | 2024-05-29 | 216 |
72 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Encore Medical L.P..
121 product recalls in 54 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 41 initiated in the last five years. Most often: Encore Medical, LP (52), Encore Medical, Lp (36), Zimmer Inc. (32).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Encore Medical L.P. is the lead sponsor of 21 device studies on ClinicalTrials.gov (1 active or recruiting). Most recent:
- NCT05101057: A Retrospective Study to Examine the Effect of CMF Stimulation on Primary ACDF Patients (Unknown, started 2021-11-15)
- NCT03711175: The Influence of Repairing the Sub-scapularis on Outcomes After Reverse Arthroplasty (Enrolling by invitation, started 2018-09-28)
- NCT02688855: CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures (Unknown, started 2017-01-23)
- NCT02720159: Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP) (Unknown, started 2015-12)
- NCT01551472: Post Market Study of the 3DKnee™ With E-plus Insert (Terminated, started 2012-04)
Parent company SEC filings
Enovis CORP (ENOV): EDGAR filings, CIK 1420800. Caduvo groups Encore Medical L.P. under Enovis (DJO); the parent's SEC registrant is entered by hand for the group, not matched by name.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Encore Orthopedics, Inc. (85 510(k)s)
- Encore Medical, L.P Dba Enovis (3 510(k)s)
- Encore Guards (2 510(k)s)
- Encore Medical Corporation (2 510(k)s)
- Encore Products, Inc. (2 510(k)s)
- Encore, Inc. (1 510(k)s)
- Encore Medical, L.P. Dba Djo Surgical (1 510(k)s)
- Encore Medical, LLC (1 510(k)s)
- Encore Technology, Inc. (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Encore Medical L.P.?
FDA lists 82 510(k) clearances under the applicant name “Encore Medical L.P.” (first 2002, latest 2026), across 17 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Encore Medical L.P.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Encore Medical L.P. is 93 days. Since 2017: 90 days, versus 101 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Encore Medical L.P.?
The most frequent FDA product codes under this applicant name are PHX (Shoulder Prosthesis, Reverse Configuration, 17); JWH (Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer, 15); LPH (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented, 12).
Next steps
- See all 82 Encore Medical L.P. clearances with predicates and recalls
- Run predicate analysis for product code PHX, Encore Medical L.P.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.